ARTICLE | Clinical News
Selincro nalmefene regulatory update
January 2, 2012 8:00 AM UTC
EMA accepted for review an MAA from H. Lundbeck for Selincro nalmefene to treat alcohol dependence. Lundbeck has rights to the opioid receptor antagonist from Biotie. ...